OR WAIT null SECS
Bioserv SMO has partnered with Clinerion and iHealth Group to add their trial sites to Clinerion's PRS platform. The Hospital São Vicente de Paulo will be the first to be implemented which will add 540 thousand new patient lives to the platform that can be accessed. With 60 ongoing studies at the hospital, this implementaion will help create a bigger field of clinical research throughout Brazil and allow for more studies to progress.
Read the full release here.